ArticleACR open rheumatology2024

Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52-Week Results From Two Phase 3 Studies.

Iain B McInnes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.